Providing review services for clinical trials on infectious diseases.
Official title: Single Institutional Review Board (sIRB)
Funded at Advarra, INC. · NIH-11080029 · Data updated 2026-11-12
This study is all about making sure that people taking part in clinical trials for infectious diseases are safe and treated fairly, with a team that checks everything to protect their rights and well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advarra, INC. NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | April 1, 2024 |
| Project end | March 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $163,718 |
| NIH project number | 75N93024D00002-0-759302400002-1 |
| Project ID | NIH-11080029 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals involved in clinical trials related to infectious diseases overseen by NIAID.
✕Less likely to help
Patients not involved in clinical trials or those with non-infectious diseases may not receive any benefit from this research.
What this research studies
This research focuses on offering Institutional Review Board (IRB) services for specific studies conducted by the National Institute of Allergy and Infectious Diseases (NIAID) in the United States. The IRB will ensure that the rights and welfare of participants in these clinical trials are protected. By reviewing study protocols and informed consent documents, the IRB plays a crucial role in overseeing the ethical conduct of research involving infectious diseases. Patients participating in these trials can expect rigorous oversight to ensure their safety and well-being.
Why it matters
Potential benefit: If successful, this research could enhance the ethical oversight of clinical trials, leading to safer and more effective treatments for infectious diseases.
How similar studies have gone: This approach of providing IRB services has been successfully implemented in other clinical trials, ensuring ethical standards are met.
Where this research is happening
-
Advarra, INC.
Columbia, United States Active
Researchers
- Principal investigator: Atkinson, Rebecca — Advarra, INC.
- Study coordinator: Atkinson, Rebecca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.